Journal List > Int J Thyroidol > v.12(1) > 1126568

Kim, Seo, Hwang, and Kim: A Case Report: Total Parathyroidectomy with Autotransplantation for Secondary Hyperparathyroidism

Abstract

Secondary hyperparathyroidism (HPT) usually result from parathyroid gland hyperplasia that produces excess parathyroid hormone (PTH). Decreased renal function leads to elevate serum phosphate levels and reduce vitamin D production, which results in hypocalcemia. Skeletal resistance to PTH results in persistently and frequently extremely elevated PTH levels and renal osteopathy. Treatment of choice for secondary HPT is medical management including calcitriol and vitamin D. However, for some cases in calciphylaxis and the failure including PTH >800 pg/mL or osteoporosis under maximal medical management surgical intervention could be an alternative option. We described a case of 47-year-old woman with surgical intervention for secondary hyperparathyroidism.

Figures and Tables

Fig. 1

Parathyroid SPECT/CT (single-photon emission computed tomography/computed tomography) findings represent multiple increased MIBI (methoxyisobutyl-isonitrile) uptake (A), right superior (B), left inferior portion of thyroid gland (C).

ijt-12-54-g001
Fig. 2

Round-shaped hyperplastic left inferior parathyroid in left level VI - paratracheal area (A), resected mass (B).

ijt-12-54-g002

Acknowledgments

This research was supported by Inha university research grant.

References

1. Jamal SA, Miller PD. Secondary and tertiary hyperparathyroidism. J Clin Densitom. 2013; 16(1):64–68.
crossref
2. Pitt SC, Sippel RS, Chen H. Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am. 2009; 89(5):1227–1239.
crossref
3. Grimelius L, Akerstrom G, Johansson H, Bergstrom R. Anatomy and histopathology of human parathyroid glands. Pathol Annu. 1981; 16(Pt 2):1–24.
4. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest. 1996; 97(11):2534–2540.
crossref
5. Parfitt AM. The hyperparathyroidism of chronic renal failure: A disorder of growth. Kidney Int. 1997; 52(1):3–9.
crossref
6. Stanbury SW, Lumb GA, Nicholson WF. Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet. 1960; 1(7128):793–799.
crossref
7. Zedenius J, Wadstrom C, Delbridge L. Routine autotransplantation of at least one parathyroid gland during total thyroidectomy may reduce permanent hypoparathyroidism to zero. Aust N Z J Surg. 1999; 69(11):794–797.
crossref
8. Richards ML, Wormuth J, Bingener J, Sirinek K. Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management? Surgery. 2006; 139(2):174–180.
crossref
9. Hibi Y, Tominaga Y, Sato T, Katayama A, Haba T, Uchida K, et al. Reoperation for renal hyperparathyroidism. World J Surg. 2002; 26(10):1301–1307.
crossref
10. Choi Y-S, Lee KE, Koo DH, Oh EM, Choi JY, Park K-w, et al. The postoperative outcomes of patients with primary, secondary and tertiary hyperparathyroidism : 14 year experience of Seoul National University Hospital. Korean J Clin Oncol. 2011; 7(1):52–59.
crossref
11. Boggs JE, Irvin GL 3rd, Molinari AS, Deriso GT. Intraoperative parathyroid hormone monitoring as an adjunct to parathyroidectomy. Surgery. 1996; 120(6):954–958.
crossref
12. Borot S, Lapierre V, Carnaille B, Goudet P, Penfornis A. Results of cryopreserved parathyroid autografts: a retrospective multicenter study. Surgery. 2010; 147(4):529–535.
crossref
TOOLS
Similar articles